Archives

by in
Entry Author Date Location
Novartis, Gilead, Genentech & More: An ASH 2013 Wrap-Up 12/10/13 National
Report: Dendreon Looking to Get Acquired 10/26/13 Seattle
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid 03/28/12 San Diego
Gates, 13 Pharmas Join $785M Push for Neglected Diseases 01/30/12 Seattle
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Amgen CEO Kevin Sharer’s Report Card: C 12/19/11 National
Two Thermo Fisher Units on Block, Bloomberg Reports 01/12/11 Boston
Report: Genoptix is on the Auction Block 12/14/10 San Diego
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Genzyme Stock Surges 15 Percent on Sanofi Buyout Speculation 07/23/10 Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders 05/13/10 Boston
Nuance Sees Opportunity in Health IT Reform, New Frontiers With iPhone Software 03/29/10 Boston
Roche, Biogen Halt Arthritis Study 03/08/10 Boston
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News 06/04/09 Seattle
Biogen Idec Showdown with Carl Icahn Culminates in Shareholder Vote Today 06/03/09 Boston
No Devil in Details: Dendreon Data Stands Up to Scrutiny from Doctors, Investors 04/28/09 Seattle
Xconomy, Seattle Post-Intelligencer Form Partnership to Share Online News, Features 12/17/08 Seattle
Bloomberg Subscribers Get Access to Sermo Physician Forum 10/23/08 Boston
Page 1 of 1